We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use °Ç¸ç³Ô¹Ï, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Help improve °Ç¸ç³Ô¹Ï
Life Sciences sector attracts over £3 billion in new public-private investment in 12 months, reflecting international confidence in UK science and innovation.
First published during the 2024 to 2026 Starmer Labour government
New partnership accelerates NHS patients' access to new medicines and will see UK benefit from greater life sciences industry investment.
Further support provided for innovative medicines as the rebate rate falls by more than third for 2026.
Milestone deal secures UK’s medicines access for patients, with a wide range of groundbreaking new treatments to reach NHS front-line quicker.
New regulations effective today will make it faster and easier for cutting-edge cancer treatments and personalised gene therapies to be made right where patients are treated.
The new Business Plan sets out priorities for 2025–26: Protecting public safety and maintaining public trust; delivering efficient, predictable services through regulatory excellence; being an agile organisation that drives …
The UK will be the first country to introduce a tailored framework for the regulation of innovative products manufactured where a patient receives care.
Four life sciences companies from across the UK will benefit from the first tranche of Life Sciences Innovative Manufacturing Fund (LSIMF) grants.
First published during the 2022 to 2024 Sunak Conservative government
Five new serious shortage protocols have been issued for penicillin.
Serious shortage protocols (SSPs) issued for 3 penicillin medicines.
Following its success during the COVID-19 pandemic, the functions of the Vaccine Taskforce will be embedded as a permanent part of government structures.
First published during the 2019 to 2022 Johnson Conservative government
Urgent action continues to be taken to ensure women across the UK will be able to more reliably access HRT products.
The government has tabled a landmark amendment to the Health and Care Bill aiming to eradicate the use of goods and services in the NHS that are tainted by slavery and human trafficking.
DHSC's Chief Commercial Officer wrote to medicines and medical product suppliers, supply chain and businesses.
2,800,000 packets of paracetamol will be distributed to leading UK supermarkets and retailers.
Allergy patients who carry Emerade 300 microgram adrenaline auto-injector pens should contact their prescriber and seek replacement pens of a different brand. This applies to Emerade 300 microgram pens that are still in-date…
More than 80 medicines used to treat patients in intensive care units have been banned from parallel export from the UK.
Patients prescribed cannabis-based medicines will be able to get their treatment in days rather than months.
New restrictions mean the MMR vaccine cannot be parallel exported from the UK, to protect stock for private patients and those not eligible for routine NHS jabs.
There will be new restrictions on exporting hormone replacement therapy (HRT) products, which currently face supply shortages due to manufacturing issues.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve °Ç¸ç³Ô¹Ï, we’d like to know more about your visit today. .